At Genentech we have nearly 40 investigational medicines in various stages of clinical trials to help in the fight against cancer.
Our investigational medicines are based on the latest science about cancer. We are studying ways to interrupt cancer cell signaling, harness the body’s natural defenses and engineer brand new classes of medicines.
RT @krystadawn: Lots of important topics at #ASCO13:QoL, combos,immunotherapies,nextgen antibodies...visit gene.com/asco for...
#ASCO13 MT @centenaryinst: Lovely animation communicating cancer research. RT @genentech: 2 scientists solve myste... ow.ly/lDpe6
MT @lungproject: #Healthcare professionals aren't immune to #lungcancer bias. See how you compare: bit.ly/R8VhJM #ASCO13
What one of our #Genentech scientists dreamt about before #ASCO13. Read on: bit.ly/10JmlU8 ow.ly/i/2gaUh
RT @genentech: #ASCOIQ: Proof of concept for anti-VEGF came from #Genentech data 10 yrs before #ASCO13 bit.ly/143Nf91 twitter.com/rx…
Facebook
Twitter
LinkedIn
YouTube
Pinterest
Google+